News
Biotechnology is often hailed as the future of cosmetic formulations. Here,, Director and Cosmetic Chemist at the Institute ...
Discover how gene editing and lab-grown meat are revolutionising healthcare and food in 2025, offering personalised ...
Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated ...
Drug Farm, a private biotechnology company utilizing genetics and artificial intelligence technologies to discover and ...
About MAIA Biotechnology, Inc. MAIA is a targeted therapy ... different from those anticipated by such statements. The use of words such as “may,” “might,” “will,” “should, ...
Treatment practices in the U.S. show approximately 75% of diagnosed pulmonary sarcoidosis patients require treatment with ...
1d
Medical Device Network on MSNASCO25: AI test shown to aid in prostate cancer treatment planningResearchers used ArteraAI to identify 25% of prostate cancer patients in a large trial cohort for whom abiraterone halved the ...
Regeneron intends for 23andMe to continue its consumer genome services without interruption. The transaction, pending ...
Title: ZW1528, a Bispecific Antibody Targeting IL-4Ra and IL-33, Potently Inhibits Key Mediators of Airway Inflammation ...
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results